ITERUM THERAPEUTICS PLC (ITRM) Stock Balance Sheet
NASDAQ:ITRM • IE000TTOOBX0
Current stock price
0.03 USD
-0.04 (-57.39%)
At close:
0.0315 USD
+0 (+5%)
After Hours:
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 11.00M | 24.13M | 6.07M | 21.09M | 27.45M | |||
| Marketable Securities | N/A | 0.00 | 17.86M | 39.75M | 53.94M | |||
| Receivables | 546.00K | 70.00K | 230.00K | 400.00K | 370.00K | |||
| Inventories | 1.15M | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 1.03M | 600.00K | 1.63M | 1.21M | 1.52M | |||
| Total Current Assets | 13.73M | 25.00M | 26.00M | 62.44M | 83.27M | |||
| Non-Current Assets | ||||||||
| PPE Net | 18.00K | 20.00K | 600.00K | 1.84M | 3.83M | |||
| Intangibles | 18.71M | 20.00M | 0.00 | 1.72M | 3.44M | |||
| Other Non-Current Assets | 48.00K | 10.00K | 30.00K | 830.00K | 980.00K | |||
| Total Non-Current Assets | 18.78M | 20.00M | 0.00 | 4.39M | 8.24M | |||
| TOTAL ASSETS | 32.50M | 45.00M | 26.00M | 66.83M | 91.51M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 281.00K | 14.00M | N/A | 0.00 | 1.63M | |||
| Accrued Expenses | 5.22M | 2.72M | 8.13M | 4.68M | 1.63M | |||
| Accounts Payable | 577.00K | 250.00K | 5.00M | 2.77M | 880.00K | |||
| Other Current Liabilities | 356.00K | 170.00K | 400.00K | 1.61M | 8.81M | |||
| Total Current Liabilities | 6.43M | 18.00M | 14.00M | 9.06M | 12.94M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 33.45M | 31.00M | 19.00M | 28.47M | 24.90M | |||
| Other Non-Current Liabilities | N/A | 0.00 | 190.00K | 1.30M | 3.44M | |||
| Total Non-Current Liabilities | 33.45M | 31.00M | 19.00M | 29.77M | 28.34M | |||
| TOTAL LIABILITIES | 39.88M | 49.00M | 33.00M | 38.83M | 41.28M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -506.45M | -486.00M | -461.00M | -422.93M | -378.49M | |||
| Additional Paid In Capital | 498.58M | 482.00M | 455.00M | 451.15M | 426.90M | |||
| Common Shares | 490.00K | 320.00K | 140.00K | 130.00K | 1.83M | |||
| Other Shareholders' Equity | 0.00 | 0.00 | 0.00 | -350.00K | N/A | |||
| Shares Outstanding | 48.99M | 32.00M | 13.00M | 12.60M | 12.19M | |||
| Tangible Book Value per Share | -0.53 | -0.75 | -0.47 | 2.09 | 3.84 | |||
| Total Shareholders' Equity | -7.38M | -4.08M | -6.40M | 28.00M | 50.23M | |||
| TOTAL LIABILITIES AND EQUITY | 32.50M | 45.00M | 26.00M | 66.83M | 91.51M | |||
| Statistics | ||||||||
| Debt/Equity | -4.53 | -7.60 | -2.97 | 1.02 | 0.50 | |||
| Current Ratio | 2.13 | 1.39 | 1.86 | 6.89 | 6.44 | |||
| Return On Assets (ROA) | -82.94% | -55.56% | -146.15% | -66.48% | -100.05% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -158.68% | -182.28% | |||
All data in USD , ROIC based on taxRate of 0.21